Histidine

Histidine

SCHEMBL7581387

NC(=O)CC(N)C(=O)O.NC(CS)C(=O)O.NC(Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.41
SLC7A11 Q9UPY5 1/20 0.41
SLC7A5 Q01650 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.36
PKM P14618 2/20 0.33
ALPI P09923 1/20 0.33
XIAP P98170 1/20 0.33
GRIA2 P42262 4/20 0.32
GRIA1 P42261 3/20 0.32
GRIA3 P42263 3/20 0.32
GRIA4 P48058 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
BLM P54132 2/20 0.32
PMP22 Q01453 2/20 0.32
KMT2A Q03164 2/20 0.32
HIF1A Q16665 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL4678808 1.00 PTGS1 (0.41) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2
Histidine SCHEMBL1673654 0.93 SLC7A5 (0.41) PTGS1SLC7A5CYP3A4CYP1A2PKM
Histidine SCHEMBL28064125 0.93 SLC7A5 (0.41) PTGS1SLC7A5CYP3A4CYP1A2PKM
Histidine SCHEMBL1673653 0.93 SLC7A5 (0.41) PTGS1SLC7A5CYP3A4CYP1A2PKM
Histidine SCHEMBL17113605 0.93 SLC7A5 (0.41) PTGS1SLC7A5CYP3A4CYP1A2PKM
Histidine SCHEMBL18047802 0.92 PTGS1 (0.48) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2
Histidine SCHEMBL851432 0.92 PTGS1 (0.48) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2
Histidine SCHEMBL22091426 0.92 PTGS1 (0.48) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2
Histidine SCHEMBL4452747 0.92 PTGS1 (0.48) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2
Histidine SCHEMBL1673287 0.92 PTGS1 (0.48) PTGS1SLC7A11SLC7A5CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1240352-A2 MOLECULES DERIVED FROM MECHANISM BASED DRUG DESIGN eXegenics Inc. (US) 2002-09-18 EP disclosed
WO-2001045836-A2 MOLECULES DERIVED FROM MECHANISM BASED DRUG DESIGN CYTOCLONAL PHARMACEUTICS, INC. (US) 2001-06-28 WO disclosed